senate Bill S6179

2011-2012 Legislative Session

Requires disclosure of addiction risks for certain prescription drugs

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Committee


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

do you support this bill?

Actions

view actions (3)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Mar 12, 2012 committee discharged and committed to rules
notice of committee consideration - requested
Jan 11, 2012 referred to health

Co-Sponsors

S6179 - Details

See Assembly Version of this Bill:
A9097
Current Committee:
Law Section:
Public Health Law
Laws Affected:
Add §3317, Pub Health L; add §19.18, Ment Hyg L

S6179 - Summary

Requires disclosure of addiction risks for certain prescription drugs; requires physicians, nurses and pharmacists to provide information on prevention, mitigation and treatment of prescription drug addiction and to have patient sign form acknowledging education of such risks.

S6179 - Sponsor Memo

S6179 - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  6179

                            I N  S E N A T E

                            January 11, 2012
                               ___________

Introduced  by  Sen. KENNEDY -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health

AN ACT to amend the public health law and the  mental  hygiene  law,  in
  relation  to  requiring  disclosure  of  addiction  risks  for certain
  prescription drugs

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  This  act shall be known and may be cited as the "Michael
David Israel patient information act".
  S 2.  The public health law is amended by adding a new section 3317 to
read as follows:
  S 3317.  REQUIRED DISCLOSURES. 1. DEFINITIONS. FOR  PURPOSES  OF  THIS
SECTION:
  (A) "OPIATE ANALGESICS" SHALL MEAN THE MEDICINES BUPRENORPHINE, BUTOR-
PHANOL,  CODEINE,  HYDROCODONE,  HYDROMORPHONE, LEVORPHANOL, MEPERIDINE,
METHADONE, MORPHINE, NALBUPHINE, OXYCODONE, OXYMORPHONE, PENTAZOCINE AND
PROPOXYPHENE AS WELL AS THEIR BRAND NAMES, ISOMERS AND COMBINATIONS.
  (B) "PSYCHOTROPIC DRUGS SHALL MEAN ANY DRUG OR MEDICINE  THAT  AFFECTS
MENTAL ACTIVITY, BEHAVIOR OR PERCEPTION INCLUDING ANTI-PSYCHOTICS, ANTI-
DEPRESSANTS, ANTI-ANXIETY DRUGS OR ANXIOLYTICS AND HYPNOTICS.
  2.  DISCLOSURES. WHENEVER A PRACTITIONER, PHARMACIST, REGISTERED NURSE
OR ANY OTHER PERSON WHO IS AUTHORIZED TO DISTRIBUTE SUBSTANCES REGULATED
BY THIS ARTICLE, DISPENSES OPIATE ANALGESICS OR PSYCHOTROPIC DRUGS  SUCH
PRESCRIBING PHYSICIAN, NURSE OR PHARMACIST SHALL:
  (A) DESCRIBE THE RISKS OF ADDICTION TO THE PATIENT;
  (B) AFTER CONSULTING THE PATIENT'S MEDICAL HISTORY, INFORM THE PATIENT
OF HIS OR HER CHANCE OF ADDICTION;
  (C)  PROVIDE  THE  PATIENT  WITH  INFORMATION ABOUT COPING WITH OPIATE
ANALGESIC OR PYSCHOTROPIC DRUG ADDICTION AND AVAILABLE  LOCAL  RESOURCES
INCLUDING DETOXIFICATION CENTERS, COUNSELING SERVICES AND HOTLINES; AND
  (D)  HAVE  THE PATIENT SIGN A FORM APPROVED BY THE DEPARTMENT ACKNOWL-
EDGING THAT HE OR SHE HAS BEEN INFORMED OF  THE  PREVENTION,  MITIGATION
AND TREATMENT OF SUCH ADDICTION.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD13590-02-1

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.